Department of Human Anatomy, Histology, and Embryology, Fourth Military Medical University, Xi'an 710032, China.
J Biol Chem. 2012 Nov 23;287(48):40471-83. doi: 10.1074/jbc.M112.383802. Epub 2012 Oct 18.
Desensitization of FSH response by down-regulation of FSHR transcription is critical for FSH action.
Chromatin modifier MTA2 participates in the down-regulation of FSHR transcription.
The FSH/Ar/MTA2 cascade may serve as an indispensable negative feedback mechanism to modulate FSH transduction events in Sertoli cells.
Our findings provide new insights into mechanisms by which FSH is deregulated in male infertile patients. The effect of follicle-stimulating hormone (FSH) on spermatogenesis is modulated at a fundamental level by controlling the number of competent receptors present at the surface of Sertoli cells (SCs). One underlying mechanism is the down-regulation of the expression levels of the FSH receptor (FSHR) gene after exposure to FSH. Here we report that metastasis-associated protein 2 (MTA2), a component of histone deacetylase and nucleosome-remodeling complexes, as a gene product induced directly by testosterone or indirectly by FSH, is exclusively expressed in SCs. Stimulation of SCs with FSH is accompanied by up-regulation of MTA2 expression and enhancement of deacetylase activity. This effect requires the integrity of functional androgen receptor. Furthermore, MTA2 is a potent corepressor of FSHR transcription, because it can recruit histone deacetylase-1 onto the FSHR promoter and participates in the down-regulation of FSHR expression upon FSH treatment. Abolishment of endogenous MTA2 by siRNA treatment disrupted the desensitization of the FSH response and thereafter impaired the FSH-dependent secretory function of SCs. From a clinical standpoint, deregulated expression of MTA2 in SCs of human pathological testes negatively correlates to the deregulated level of serum FSH. Overall, our present results provide the first evidence that the FSH/androgen receptor/MTA2 cascade may serve as an indispensable negative feedback mechanism to modulate the transduction events of SCs in response to FSH. These data also underscore an unexpected reproductive facet of MTA2, which may operate as a novel integrator linking synergistic actions of FSH and androgen signaling in SCs.
通过下调 FSHR 转录来使 FSH 反应脱敏对于 FSH 作用至关重要。
染色质修饰剂 MTA2 参与 FSHR 转录的下调。
FSH/Ar/MTA2 级联可能作为一种不可或缺的负反馈机制,调节支持细胞中 FSH 的转导事件。
我们的研究结果为男性不育患者中 FSH 失调的机制提供了新的见解。卵泡刺激素 (FSH) 对生精作用的影响在根本上是通过控制生精细胞 (SCs) 表面存在的功能受体数量来调节的。一种潜在的机制是 FSH 暴露后 FSH 受体 (FSHR) 基因表达水平的下调。在这里,我们报告转移性蛋白 2 (MTA2),一种组蛋白去乙酰化酶和核小体重塑复合物的组成部分,作为直接由睾酮诱导或间接由 FSH 诱导的基因产物,仅在 SCs 中表达。用 FSH 刺激 SCs 会导致 MTA2 表达上调和去乙酰化酶活性增强。这种效应需要功能性雄激素受体的完整性。此外,MTA2 是 FSHR 转录的强有力的核心抑制子,因为它可以将组蛋白去乙酰化酶-1募集到 FSHR 启动子上,并在 FSH 处理时参与 FSHR 表达的下调。用 siRNA 处理消除内源性 MTA2 会破坏 FSH 反应的脱敏,随后损害 SCs 的 FSH 依赖性分泌功能。从临床角度来看,病理性睾丸中 SCs 的 MTA2 表达失调与血清 FSH 的失调水平呈负相关。总的来说,我们的研究结果首次提供了证据表明,FSH/雄激素受体/MTA2 级联可能作为一种不可或缺的负反馈机制,调节支持细胞对 FSH 的转导事件。这些数据还强调了 MTA2 的一个意外生殖方面,它可能作为一个新的整合因子,将 FSH 和雄激素信号在 SCs 中的协同作用联系起来。